These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low molar excess of 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote oligomerization of alpha-synuclein through different pathways. Almandoz-Gil L; Welander H; Ihse E; Khoonsari PE; Musunuri S; Lendel C; Sigvardson J; Karlsson M; Ingelsson M; Kultima K; Bergström J Free Radic Biol Med; 2017 Sep; 110():421-431. PubMed ID: 28690195 [TBL] [Abstract][Full Text] [Related]
7. SDS-induced fibrillation of alpha-synuclein: an alternative fibrillation pathway. Giehm L; Oliveira CL; Christiansen G; Pedersen JS; Otzen DE J Mol Biol; 2010 Aug; 401(1):115-33. PubMed ID: 20540950 [TBL] [Abstract][Full Text] [Related]
8. Seed-dependent accelerated fibrillation of alpha-synuclein induced by periodic ultrasonication treatment. Kim HJ; Chatani E; Goto Y; Paik SR J Microbiol Biotechnol; 2007 Dec; 17(12):2027-32. PubMed ID: 18167451 [TBL] [Abstract][Full Text] [Related]
9. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137 [TBL] [Abstract][Full Text] [Related]
10. Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins. Schnack C; Danzer KM; Hengerer B; Gillardon F Neuroscience; 2008 Jul; 154(4):1450-7. PubMed ID: 18541383 [TBL] [Abstract][Full Text] [Related]
11. Structural properties of pore-forming oligomers of alpha-synuclein. Kim HY; Cho MK; Kumar A; Maier E; Siebenhaar C; Becker S; Fernandez CO; Lashuel HA; Benz R; Lange A; Zweckstetter M J Am Chem Soc; 2009 Dec; 131(47):17482-9. PubMed ID: 19888725 [TBL] [Abstract][Full Text] [Related]
12. Lipid peroxidation product 4-hydroxy-2-nonenal promotes seeding-capable oligomer formation and cell-to-cell transfer of α-synuclein. Bae EJ; Ho DH; Park E; Jung JW; Cho K; Hong JH; Lee HJ; Kim KP; Lee SJ Antioxid Redox Signal; 2013 Mar; 18(7):770-83. PubMed ID: 22867050 [TBL] [Abstract][Full Text] [Related]
13. Small molecule oxidation products trigger disease-associated protein misfolding. Bieschke J; Zhang Q; Bosco DA; Lerner RA; Powers ET; Wentworth P; Kelly JW Acc Chem Res; 2006 Sep; 39(9):611-9. PubMed ID: 16981677 [TBL] [Abstract][Full Text] [Related]
14. Fibrillogenic and non-fibrillogenic ensembles of SDS-bound human alpha-synuclein. Ahmad MF; Ramakrishna T; Raman B; Rao ChM J Mol Biol; 2006 Dec; 364(5):1061-72. PubMed ID: 17054982 [TBL] [Abstract][Full Text] [Related]
16. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. Cappai R; Leck SL; Tew DJ; Williamson NA; Smith DP; Galatis D; Sharples RA; Curtain CC; Ali FE; Cherny RA; Culvenor JG; Bottomley SP; Masters CL; Barnham KJ; Hill AF FASEB J; 2005 Aug; 19(10):1377-9. PubMed ID: 15946991 [TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein multistate folding thermodynamics: implications for protein misfolding and aggregation. Ferreon AC; Deniz AA Biochemistry; 2007 Apr; 46(15):4499-509. PubMed ID: 17378587 [TBL] [Abstract][Full Text] [Related]
18. Assembly of alpha-synuclein fibrils in nanoscale studied by peptide truncation and AFM. Zhang F; Lin XJ; Ji LN; Du HN; Tang L; He JH; Hu J; Hu HY Biochem Biophys Res Commun; 2008 Apr; 368(2):388-94. PubMed ID: 18230346 [TBL] [Abstract][Full Text] [Related]
19. Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid. De Franceschi G; Frare E; Bubacco L; Mammi S; Fontana A; de Laureto PP J Mol Biol; 2009 Nov; 394(1):94-107. PubMed ID: 19747490 [TBL] [Abstract][Full Text] [Related]
20. Effect of 4-hydroxy-2-nonenal modification on alpha-synuclein aggregation. Qin Z; Hu D; Han S; Reaney SH; Di Monte DA; Fink AL J Biol Chem; 2007 Feb; 282(8):5862-70. PubMed ID: 17189262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]